Patents by Inventor Bárbara Athayde Vaz Galvão da Silva

Bárbara Athayde Vaz Galvão da Silva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits
    Patent number: 11034735
    Abstract: The present invention relates to novel hybrid peptides developed from the combination of membrane surface protein peptide fragments present in anaplasmosis microorganisms, and in particular, bacteria of the species Anaplasma marginale. The present invention further relates to hybrid peptide sets, compositions and kits comprising such novel hybrid peptides, their uses and methods of inducing immune response. Each hybrid peptide, according to the present invention, comprises two or more peptide fragments of amino acid sequences as defined in the present invention linked together by means of a spacer element. The combined peptide fragments are protein peptide fragments of MSP1, MSP1a, MSP1b, MSP2, MSP2-HRV, MSP3, OMP7, OMP8, VirB9 and VirB10.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: June 15, 2021
    Assignees: BIOTICK PESQUISA E DESENVOLVIMENTO TECNOLÓGICO LTDA., FUNDAÇÃO BUTANTAN
    Inventors: Ana Marisa Chudzinski-Tavassi, Bárbara Athayde Vaz Galväo da Silva, Kerly Fernanda Mesquita Pasqualoto, Leo Kei Iwai, Rafael Marques Porto
  • HYBRID PEPTIDE, SET OF HYBRID PEPTIDES, COMPOSITION, USES OF THE HYBRID PEPTIDE, METHOD FOR INDUCING AN IMMUNE RESPONSE AND KITS
    Publication number: 20200095289
    Abstract: The present invention relates to novel hybrid peptides developed from the combination of membrane surface protein peptide fragments present in anaplasmosis microorganisms, and in particular, bacteria of the species Anaplasma marginale. The present invention further relates to hybrid peptide sets, compositions and kits comprising such novel hybrid peptides, their uses and methods of inducing immune response. Each hybrid peptide, according to the present invention, comprises two or more peptide fragments of amino acid sequences as defined in the present invention linked together by means of a spacer element. The combined peptide fragments are protein peptide fragments of MSP1, MSP1a, MSP1b, MSP2, MSP2-HRV, MSP3, OMP7, OMP8, VirB9 and VirB10.
    Type: Application
    Filed: February 9, 2018
    Publication date: March 26, 2020
    Inventors: Ana Marisa Chudzinski-Tavassi, Bárbara Athayde Vaz Galvão da Silva, Kerly Fernanda Mesquita Pasqualoto, Leo Kei Iwai, Rafael Marques Porto